Bayer Animal Health Products Philippines
SHAWNEE, Kan., Dec. 7, 2016 // --Bayer and Boehringer Ingelheim Vetmedica, Inc. (BIVI) today announced that they have signed an agreement under which, on completion of the transaction, Bayer would acquire BIVI's CYDECTIN bovine and ovine endectocide products in the U.S.
Once completed, the deal would include the transfer of CYDECTIN Pour-On, CYDECTIN Injectable and CYDECTIN Oral Drench. These endectocides with the active ingredient moxidectin offer persistent killing of internal parasites at multiple stages, including the most economically devastating parasite, Ostertagia ostertagi (brown stomach worm) and controls external parasites including lice, grubs and psoroptic mange mites on beef and dairy cattle.
This transaction underlines our strategy to strengthen our portfolio with bolt-on acquisitions, said Dr. Dirk Ehle, Head of Bayer Animal Health. The U.S. is our most important market, and the addition of the CYDECTIN products will help further strengthen our position in cattle parasiticides in the U.S.
Aviboost Tonic Concentrated Animal Supplement Produced By Bayer Animal Health: Buy Online At Best Price In Egypt
The CYDECTIN products are a perfect addition to our U.S. product portfolio, added Joyce Lee, Head of Commercial Operations for Animal Health, North America. They are complementary to our existing parasiticides portfolio, propelling Bayer's strong position from the ectoparasitic space to now include endectocides.
We are pleased that veterinarians and cattle producers will continue to have access to the CYDECTIN line, and we are confident these products will have strong support after the sale with Bayer, said Dr. Albrecht Kissel, president and CEO of BIVI.
The sale of BIVI's U.S. CYDECTIN products is a required step toward BI's acquisition of Merial as part of the larger swap transaction between Sanofi and BI.
Treatments For Digestive Problems In Animals
Bayer: Science For A Better Life Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2015, the Group employed around 117, 000 people and had sales of EUR 46.3 billion. Capital expenditures amounted to EUR 2.6 billion, R&D expenses to EUR 4.3 billion. These figures include those for the high-tech polymers business, which was floated on the stock market as an independent company named Covestro on Oct. 6, 2015. For more information, go to www.bayer.com.
About Boehringer Ingelheim Vetmedica, Inc. (BIVI) Boehringer Ingelheim Vetmedica Inc. (BIVI), is the U.S. animal health division of Boehringer Ingelheim GmbH. BIVI develops, manufactures and markets novel and innovative solutions for the prevention and treatment of disease in the cattle, equine, pet and swine markets. BIVI is the fifth largest animal health company in the U.S. The company has 2, 000 employees unleashing their collective passion to keep animals healthy every day.
With more than 3, 800 employees worldwide, Boehringer Ingelheim Animal Health achieved net sales of about 1.4 billion euros in 2015. In its research-driven Animal Health business, Boehringer Ingelheim continually invests more than 11 percent of net sales of the Animal Health business in R&D.
Boehringer Ingelheim Animal Health Products
Boehringer Ingelheim is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, Boehringer Ingelheim operates globally through 145 affiliates and a total of some 47, 500 employees. Founded in 1885, the focus of the family-owned company is on researching, developing, manufacturing and marketing new medications of high therapeutic value for human and veterinary medicine.
Forward-Looking Statements This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.
Bayer anuncia mudanças na liderança de sua divisão agrícola A Bayer está realizando uma série de mudanças importantes no Comitê de Liderança Executiva de sua divisão agrícola. A nova configuração contribuirá...
Veterinary Pharmaceutical Drug Market Size In 2023
Edital para empresas participarem de farm lab da Embrapa está disponível Em 04 de dezembro saiu o Edital de Oferta Tecnológica 01/2023 para selecionar empresa para exercer a função de Gestor Operacional do AgNest Farm Lab, ...
By signing up you agree to receive content from us. Our newsletters contain tracking pixels to help us deliver unique content based on each subscriber's engagement and interests. For more information on how we will use your data to ensure we send you relevant content please visit our PRN Consumer Newsletter Privacy Notice. You can withdraw your consent at any time in the footer of every email you'll receive. Mit Ihrer Anmeldung erklären Sie sich damit einverstanden, Inhalte von uns zu erhalten. Unsere Newsletter enthalten Zählpixel, die die Lieferung einzigartiger Inhalte in Bezug auf das Abonnement und die Interessen der einzelnen Abonnenten ermöglichen. Weitere Informationen über die Verwendung Ihrer Daten im Hinblick auf die Zusendung von relevanten Inhalten, finden Sie in unserer PRN Consumer Newsletter Privacy Notice. Ihre Zustimmung können Sie jederzeit in der Fußzeile jeder erhaltenen E-Mail widerrufen. En vous inscrivant à la newsletter, vous consentez à la réception de contenus de notre part. Notre newsletter contient des pixels espions nous permettant la fourniture à chaque abonné, d’un contenu unique en lien avec ses souscriptions et intérêts. Pour de plus amples informations sur l’utilisation faite de vos données en vue de l’envoi des contenus concernés, nous vous invitons à consulter la politique de confidentialité disponible à partir du lien suivant PRN Consumer Newsletter Privacy Notice. Vous pouvez à tout moment revenir sur votre consentement par le biais des informations situées au bas de chaque e-mail reçu. Регистрирайки се, Вие се съгласявате да получавате информационно съдържание от нас. Нашите бюлетини съдържат проследяващи пиксели, които ни помагат да предоставяме уникално съдържание въз основа на ангажираността и интересите на всеки абонат. За повече информация относно начина, по който ще използваме Вашите данни, за да гарантираме, че Ви изпращаме подходящо съдържание, моля, направете справка с нашето Уведомление за поверителност на потребителския бюлетин на PRN. Можете да оттеглите съгласието си по всяко време в долния колонтитул на всеки от имейлите, които ще получите.Tick and flea infestations are more than just a nuisance; they also pose a very real threat to both pets and humans as they can transmit serious diseases. These diseases have become more frequently diagnosed and more geographically widespread, increasing both the danger posed to pets and the risk posed to humans.
Last September 15, 2017 Bayer Animal Health launched its newest product- the Seresto, a flea and tick collar for dogs and cats in the Philippines which was held at Fairmont Hotel, Raffles 1 Drive, Makati City.
Bayer Animal Health 023 81127018 500 Ml Cydectin India
There were over hundred veterinarians and partners who attended the launch event. Aside from these people, there were also experts who were also present like Dr. Remil Gelay, Assistant Professor from the UP College of Veterinary Medicine, and Dr. Ta-Li Lu, Cardiologist at Cardiospecial vetirinary hospital in Taiwan to discuss pressing animal health topics like tick biology, tick-borne disease, current situation of canine TBDs in the Philippines and, vector-borne disease management and diagnostics.
Dr. Susanne Siebert of Bayer’s Global Companion Animal Marketing Group introduces Bayer’s new dog and cat collar which provides up to eight months continuous protection against fleas and ticks.
In dogs, many of these tick and flea diseases can be lethal and hard to be treated, meaning that prevention is key to their management. The most effective disease prevention technique is to stop parasites from biting, commonly referred to as ‘repellency’, which help reduce the risk of disease transmission. However, through Bayer Animal Health’s latest product, the Seresto, it will provide pets up to eight months of continuous protection, even through a single application.
Buy Bayopet Organic Dog Soap Products Online
Seresto® is unique in combining the leading insecticides, imidacloprid and the highly effective acaricide flumethrin. These compounds are embedded in an innovative waterproof, odor-free collar made of a polymer matrix. The collar’s materials ensure that the active ingredients are consistently released in low dosages that is friendly not only to furrents but to furbabies as well. It can be purchased through a prescription of an authorized veterinarian and is avaible in a collar of two sizes that can be worn by both cats and dogs, designed to stay securely in place and effectively provides long-term protection against fleas and ticks for up to eight months.
As we prepare to celebrate the Chinese Lunar New Year 2024 in the Philippines, one place that stands out in the heart of the festivities is The Empress Dining Palace, a Chinese fine dining restaurant in BGC, Taguig City.
Whether you're a lover of Japanese culture or just looking for a fun way to spend your evening, the Manila Japanese Bon Odori Festival is where you need to be. Let's dance, eat, and celebrate together under the Manila sky!
Bayer Pet Products, Bayer Animal Health, Bayer Tick Collar
Filipina-Japanese Actress Yana Sonoda shares how she celebrated Christmas and New Year in the Philippines in this exclusive column with Philippine !
Your dream of traveling the world is now within reach as
Posting Komentar untuk "Bayer Animal Health Products Philippines"